Gildan Activewear (NYSE:GIL) (TSX:GIL) shares fell 2.8% on Tuesday after Jehoshaphat Research published a short report that challenges the fundamentals behind the Canadian apparel maker's reported revenue gains.
The research firm, which disclosed it holds a short position in the company, contends that Gildan's reported top-line growth disguises an ongoing decline in organic demand. Jehoshaphat Research argues that the apparent revenue expansion has been supported by what it describes as financial engineering rather than underlying end-user sales growth.
Central to the report is the allegation that Gildan has been "stuffing" its distribution channel with product in excess of true end-user demand. Jehoshaphat Research estimates this inventory overhang at around $500 million, and says that figure stands in contrast to consensus forecasts for 2026 cited in the report's summary.
Jehoshaphat Research draws on interviews with former employees and distributors to support its assertions, recounting accounts of aggressive commercial tactics. The report details practices it characterizes as pressuring distributors to accelerate purchases and extending payment or delivery terms at the ends of quarters to shift sales from one period into another. Examples cited include measures intended to move sales from Q2 into Q1.
The short seller also raises governance questions, noting the timing of these alleged changes in sales behavior. Jehoshaphat Research asks whether the patterns it describes began around 2024, after what it calls a mass resignation of Gildan's board of directors. The firm suggests the new board may be less inclined to exert the same level of oversight over management as the prior board.
In addition, the report flags the Hanes acquisition as an added complication for Gildan, although the summary stops short of offering detailed allegations about that transaction. Jehoshaphat Research directs readers to its website for the full short thesis and for its financial interest disclosures.
Investors reacted to the publication of the short report with a modest decline in the stock, reflecting market sensitivity to questions about inventory levels, sales recognition and board oversight. The report's assertions, if accurate, could bear on working-capital dynamics, distributor relationships and the conversion of reported sales into sustainable end-market demand.
What to watch next
- Whether Gildan issues a public response to the allegations detailed in Jehoshaphat Research's report.
- Any updates to consensus forecasts that incorporate the report's estimate of a roughly $500 million product overhang.
- Signals from distributors and former employees that corroborate or refute the accounts cited by the short seller.